Jazz Pharmaceuticals plc Quarterly Other Liabilities, Noncurrent in USD from Q4 2011 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary: Jazz Pharmaceuticals plc quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2011 to Q1 2025.
Jazz Pharmaceuticals plc Other Liabilities, Noncurrent for the quarter ending March 31, 2025 was $91.1M, a 6.47% decline year-over-year.

Other Liabilities, Noncurrent, Quarterly (USD)

Other Liabilities, Noncurrent, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$91.1M	-$6.31M	-6.47%	Mar 31, 2025	10-Q	2025-05-07
Q4 2024	$86.6M	-$18.1M	-17.3%	Dec 31, 2024	10-Q	2025-05-07
Q3 2024	$111M	-$16.5M	-13%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$99.4M	-$27.3M	-21.5%	Jun 30, 2024	10-Q	2024-08-01
Q1 2024	$97.4M	-$11.8M	-10.8%	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$105M	-$2.06M	-1.93%	Dec 31, 2023	10-K	2025-02-26
Q3 2023	$127M	+$3.55M	+2.86%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$127M	-$2.74M	-2.12%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$109M	-$15.5M	-12.4%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$107M	-$10.2M	-8.71%	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$124M	-$13.9M	-10.1%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$129M	-$3.09M	-2.33%	Jun 30, 2022	10-Q	2022-08-03
Q1 2022	$125M	+$18.8M	+17.7%	Mar 31, 2022	10-Q	2022-05-04
Q4 2021	$117M	+$15.9M	+15.7%	Dec 31, 2021	10-K	2023-03-01
Q3 2021	$138M	-$4.67M	-3.28%	Sep 30, 2021	10-Q	2021-11-09
Q2 2021	$133M	-$2.33M	-1.73%	Jun 30, 2021	10-Q	2021-08-03
Q1 2021	$106M	-$11.4M	-9.71%	Mar 31, 2021	10-Q	2021-05-04
Q4 2020	$101M	-$8.23M	-7.52%	Dec 31, 2020	10-K	2022-03-01
Q3 2020	$142M	+$39.9M	+38.9%	Sep 30, 2020	10-Q	2020-11-02
Q2 2020	$135M	+$14.1M	+11.7%	Jun 30, 2020	10-Q	2020-08-04
Q1 2020	$117M	+$5.36M	+4.79%	Mar 31, 2020	10-Q	2020-05-05
Q4 2019	$109M	-$110M	-50%	Dec 31, 2019	10-K	2021-02-23
Q3 2019	$103M	-$106M	-50.8%	Sep 30, 2019	10-Q	2019-11-05
Q2 2019	$121M	-$85M	-41.3%	Jun 30, 2019	10-Q	2019-08-06
Q1 2019	$112M	-$80.3M	-41.8%	Mar 31, 2019	10-Q	2019-05-07
Q4 2018	$219M	+$42.3M	+23.9%	Dec 31, 2018	10-K	2020-02-25
Q3 2018	$209M	+$50.2M	+31.6%	Sep 30, 2018	10-Q	2018-11-06
Q2 2018	$206M	+$61M	+42.2%	Jun 30, 2018	10-Q	2018-08-07
Q1 2018	$192M	+$63.4M	+49.2%	Mar 31, 2018	10-Q	2018-05-08
Q4 2017	$177M	+$64M	+56.8%	Dec 31, 2017	10-K	2019-02-26
Q3 2017	$158M	+$52.4M	+49.4%	Sep 30, 2017	10-Q	2017-11-07
Q2 2017	$145M	+$50.5M	+53.6%	Jun 30, 2017	10-Q	2017-08-08
Q1 2017	$129M	+$49.6M	+62.6%	Mar 31, 2017	10-Q	2017-05-09
Q4 2016	$113M	+$43.4M	+62.6%	Dec 31, 2016	10-K	2018-02-27
Q3 2016	$106M	+$46.4M	+77.8%	Sep 30, 2016	10-Q	2016-11-08
Q2 2016	$94.2M	+$41.5M	+78.9%	Jun 30, 2016	10-Q	2016-08-09
Q1 2016	$79.2M	+$34.1M	+75.5%	Mar 31, 2016	10-Q	2016-05-10
Q4 2015	$69.3M	+$30.9M	+80.4%	Dec 31, 2015	10-K	2017-02-28
Q3 2015	$59.7M	+$26.1M	+77.6%	Sep 30, 2015	10-Q	2015-11-09
Q2 2015	$52.7M	+$23.5M	+80.5%	Jun 30, 2015	10-Q	2015-08-05
Q1 2015	$45.1M	+$19.7M	+77.7%	Mar 31, 2015	10-Q	2015-05-07
Q4 2014	$38.4M	+$18.4M	+91.6%	Dec 31, 2014	10-K	2016-02-23
Q3 2014	$33.6M	+$16.8M	+101%	Sep 30, 2014	10-Q	2014-11-04
Q2 2014	$29.2M	+$15.8M	+119%	Jun 30, 2014	10-Q	2014-08-05
Q1 2014	$25.4M	+$15.6M	+159%	Mar 31, 2014	10-Q	2014-05-08
Q4 2013	$20M	+$13.4M	+203%	Dec 31, 2013	10-K	2015-02-24
Q3 2013	$16.7M	+$14.6M	+675%	Sep 30, 2013	10-Q	2013-11-05
Q2 2013	$13.3M	+$11.7M	+725%	Jun 30, 2013	10-Q	2013-08-06
Q1 2013	$9.82M	+$8.5M	+647%	Mar 31, 2013	10-Q	2013-05-07
Q4 2012	$6.62M	+$6.62M		Dec 31, 2012	10-K	2014-02-25

Previous1 2Next

Showing 1 to 50 of 54 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.